NEW YORK (AP) _ Intercept Pharmaceuticals Inc. (ICPT) on Wednesday reported a loss of $64.5 million in its third quarter.
The New York-based company said it had a loss of $2.18 per share.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $2.65 per share.
The drugmaker posted revenue of $47 million in the period, also exceeding Street forecasts. Seven analysts surveyed by Zacks expected $46.6 million.
Intercept shares have increased 49 percent since the beginning of the year. The stock has increased 42 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ICPT at https://www.zacks.com/ap/ICPT